Validation of Manhattan risk to predict aGvHD severity in Rapamycin and PTCy-based prophylaxis: a study on 459 consecutive HCT patients. - Criscimanna A; Galimard JE; Auriemma MC; Lazzari L; Diral E; Bruno A; Piemontese S; Clerici D; Mastaglio S; Vago L; Greco R; Farina F; et al. (Bone marrow transplantation, 2025)